Updates are available Correction dated 2019-08-12
Click to view Correction: https://doi.org/10.1038/s41587-019-0253-5
-
Authors
Thuronyi, B W. https://orcid.org/0000-0003-0821-3791
Koblan, Luke W.
Levy, Jonathan M. https://orcid.org/0000-0002-8061-7953
Yeh, Wei-Hsi
Zheng, Christine
Newby, Gregory A. https://orcid.org/0000-0001-7869-2615
Wilson, Christopher https://orcid.org/0000-0002-8012-2440
Bhaumik, Mantu
Shubina-Oleinik, Olga
Holt, Jeffrey R. https://orcid.org/0000-0002-7182-8011
Liu, David R. https://orcid.org/0000-0002-9943-7557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-17-2-0049)
Howard Hughes Medical Institute (Liu Investigatorship)
- License Information
-
More Information
Article History
Received: 21 December 2018
Accepted: 14 June 2019
First Online: 22 July 2019
Change Date: 12 August 2019
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-019-0253-5
Competing interests
: D.R.L. is a consultant and co-founder of Beam Therapeutics, Editas Medicine and Pairwise Plants, companies that use genome editing. D.R.L., B.W.T. and C.W. have filed patent applications on aspects of this work.
